STAND Against Emerging Opioids Act

HR 7068, the STAND Against Emerging Opioids Act, adds tianeptine and its analogues, salts, isomers, and salts of isomers to Schedule III of the Controlled Substances Act. This makes tianeptine a federally controlled substance with potential for abuse, directly affecting individuals who use or distribute it. The key provision specifies the exact chemical forms included to prevent evasion of the scheduling. The change takes effect 90 days after the bill is enacted. This is a policy change to regulate a substance with emerging misuse concerns.